NDC 0008-1211 – Pristiq Extended-Release
Desvenlafaxine Succinate 50 mg/1 · Tablet, Extended Release · Oral
Product NDC0008-1211
Product details
- Brand name
- Pristiq Extended-Release
- Generic name
- Desvenlafaxine succinate
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA021992
- Marketed since
- May 1, 2008
- Listing expires
- December 31, 2027
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Active ingredients
- Desvenlafaxine Succinate 50 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 0008-1211-01 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-01) | May 1, 2008 |
| 0008-1211-14 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-14) | May 1, 2008 |
| 0008-1211-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-30) | May 1, 2008 |
| 0008-1211-50 | 100 BLISTER PACK in 1 CARTON (0008-1211-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | May 1, 2008 |
Recalls mentioning this NDC
- D-1409-2014 Jul 2, 2014 · Class II
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.